$1.43
1.42% yesterday
Nasdaq, May 01, 10:08 pm CET
ISIN
US3741631036
Symbol
GERN
Sector
Industry

Geron Corporation Stock price

$1.43
-0.05 3.38% 1M
-2.68 65.21% 6M
-2.11 59.60% YTD
-2.65 64.95% 1Y
-0.06 4.03% 3Y
+0.25 21.19% 5Y
-2.50 63.61% 10Y
Nasdaq, Closing price Thu, May 01 2025
+0.02 1.42%
ISIN
US3741631036
Symbol
GERN
Sector
Industry

Key metrics

Market capitalization $910.79m
Enterprise Value $748.87m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 9.73
P/S ratio (TTM) P/S ratio 11.83
P/B ratio (TTM) P/B ratio 3.09
Revenue growth (TTM) Revenue growth 32,387.34%
Revenue (TTM) Revenue $77.00m
EBIT (operating result TTM) EBIT $-173.73m
Free Cash Flow (TTM) Free Cash Flow $-219.30m
Cash position $408.43m
EPS (TTM) EPS $-0.27
P/E forward negative
P/S forward 4.16
EV/Sales forward 3.42
Short interest 10.21%
Show more

Is Geron Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,788 stocks worldwide.

Geron Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Geron Corporation forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Geron Corporation forecast:

Buy
78%
Hold
22%

Financial data from Geron Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
77 77
31,983% 31,983%
100%
- Direct Costs 2.16 2.16
-
3%
75 75
-
97%
- Selling and Administrative Expenses 144 144
114% 114%
187%
- Research and Development Expense 104 104
17% 17%
135%
-173 -173
11% 11%
-224%
- Depreciation and Amortization 1.22 1.22
18% 18%
2%
EBIT (Operating Income) EBIT -174 -174
10% 10%
-226%
Net Profit -175 -175
5% 5%
-227%

In millions USD.

Don't miss a Thing! We will send you all news about Geron Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Geron Corporation Stock News

Neutral
GlobeNewsWire
3 days ago
Investors can contact the law firm at no cost to learn more about recovering their losses
Neutral
Accesswire
4 days ago
NEW YORK CITY, NY / ACCESS Newswire / April 28, 2025 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Geron To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Geron between February 28, 2024 to February 25, 2025 and would like to discuss your legal rights, call Faruq...
Neutral
Business Wire
4 days ago
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of Geron Corporation (NASDAQ: GERN) securities between February 28, 2024 and February 25, 2025. Geron is a commercial-stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give...
More Geron Corporation News

Company Profile

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Head office United States
CEO Dawn Bir
Employees 229
Founded 1990
Website www.geron.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today